David J Jackson

31PUBLICATIONS
235CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Gene and molecular therapyCharacterisation of biological macromoleculesMolecular imaging (incl. electron microscopy and neutron diffraction)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Aug 25, 2026
Association of Easier Biologic Access with Remission and Other Clinical Outcomes in Severe Asthma: A Global Real-World Study.

|Feb 25, 2026
Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: a multicenter, randomized, double-blind, phase 3A clinical trial (NIMBLE).

Geoffrey Chupp, Hiroyuki Nagase, Dirk Skowasch

|May 30, 2025
Advancing Remission in Severe Asthma With Benralizumab: Latest Findings, Current Perspectives and Future Direction.

Renaud Louis, Marek Lommatzsch, David J Jackson

|May 14, 2025
Clinical and Biological Remission With Tezepelumab: The Real-World Response in Severe Uncontrolled Asthma.

Jessica Gates, Faizan Haris, Francesca Cefaloni

|Dec 16, 2024
The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in Asthma: An EAACI Position Paper.

I Agache, I M Adcock, C A Akdis

|Oct 28, 2024
STING-dependent induction of neutrophilic asthma exacerbation in response to house dust mite.

Yasmine Messaoud-Nacer, Elodie Culerier, Stéphanie Rose

Pageof 6

Frequent Collaborators

5 joint publications

Luis Perez-de-Llano

4 joint publications

David B Price

3 joint publications

Jaideep Dhariwal

3 joint publications

Ioana Agache